FACTIVE

This brand name is authorized in Brazil, Ecuador, Mexico, Tunisia, Turkey, South Africa

Active ingredients

The drug FACTIVE contains one active pharmaceutical ingredient (API):

1 Gemifloxacin UNII X4S9F8RL01 - GEMIFLOXACIN MESYLATE

Gemifloxacin is a quinolone that has in vitro activity against a wide range of Gram-negative and Gram-positive microorganisms. Gemifloxacin acts by inhibiting DNA synthesis through the inhibition of both DNA gyrase and topoisomerase IV (TOPO IV), which are essential for bacterial growth.

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FACTIVE Tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01MA15	Gemifloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 500511801116215, 500511802112213
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 5097-MEE-0420
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 229M2006
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6653511
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699514097587, 8699514097594
Country: ZA	Health Products Regulatory Authority	Identifier(s): 35/20.1.1/0058